
Considerations for pharmaceutical studies of prophylactic self-amplifying RNA vaccines
Considerations for pharmaceutical studies of prophylactic self-amplifying RNA vaccines
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |